Account
BBH India is BookMyShow’s creative partner
MUMBAI: BookMyShow has appointed BBH India (Bartle Bogle Hegarty India) as its creative strategy & advertising agency partner as part of which BBH India will now spearhead the development of business-driven marketing campaigns and concepts for BookMyShow.
BookMyShow is India’s largest online entertainment ticketing portal, with over 4000 screens on its platforms, and presence in more than 400 cities and towns across India. It recently created history by alone selling over three million movie tickets for the Christmas weekend in 2016.
BookMyShow VP- business intelligence and marketing Marzdi Kalianiwala said, “BookMyShow is a consumer driven brand that continuously strives to enhance its offering & user experience. Considering the business dynamism, it was imperative to align ourselves with a creative partner that not only would be able to match the required scale, but also demonstrate creative actions that impact key metrics. We saw BBH India to be a perfect fit and are extremely excited to begin this journey with them.”
BBH India managing director Arvind Krishnan added, “We are thrilled to be partnering with BookMyShow. It is a great platform for us to showcase our brand of creativity, through the line. The app is the product; the app is the medium and there are plenty of opportunities along the consumer journey to create impact.”
BBH India is known for its category-changing campaigns such as Uber’s ‘Move Forward’; Google’s ‘The web is what you make of it’; Magnum ‘Brown is in’ & Johnny Walker ‘The Journey’.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
